|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06606 NH HEALTH
Nominal 
14.140 0.000 (0.000%) | 2022/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |
| Turnover | 764,960 | 259.540% | 212,761 | 70,567 | 58,275 | 18,816 |
| Cost of Sales | (118,790) | 104.402% | (58,116) | (33,318) | (23,957) | (14,976) |
| Gross Profit | 646,170 | 317.841% | 154,645 | 37,249 | 34,318 | 3,840 |
| 2022/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | (19,217) | (26,900) | (338) | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (79,658) | -97.418% | (3,085,336) | (788,421) | (106,235) | (224,869) | |
| Taxation | (655) | -- | 0 | (303) | (230) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,075 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (79,238) | -97.432% | (3,085,336) | (788,724) | (106,465) | (224,869) | |
| 2022/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (5,158) | -39.995% | (8,596) | 3,612 | (592) | (1,097) |
| Depreciation & Amortisation | 26,326 | 36.588% | 19,274 | 14,874 | 13,378 | 11,933 |
| Directors' Emoluments | 60,665 | 142.786% | 24,987 | 16,455 | 11,311 | 7,897 |
| 2022/12 - Final | %Chg (Compare to Final) | 2021/12 | 2020/12 | 2019/12 | 2018/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2022/12 - Final | %Chg (Compare to Final) | 2021/12 | 2020/12 | 2019/12 | 2018/12 | |
| EPS (cts) | -19.000 | -97.669% | -815.000 | -664.000 | -92.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.975) | -- | (0.937) | (1.114) | (0.651) | -- |
| NBV per share ($) | 4.934 | -- | 4.949 | -- | -- | -- |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 125,654,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.260 |
| NBV Per Share (¥) | RMB 6.525 |